(Q44451645)

3 December 2017

title

The interaction of metal ions and Marimastat with matrix metalloproteinase 9. (English)

1 reference

3 December 2017

2

1 reference

3 December 2017

Underwood CK

1

1 reference

3 December 2017

Lyons JG

series ordinal

3

1 reference

3 December 2017

Hambley TW

series ordinal

4

1 reference

3 December 2017

publication date

1 June 2003

1 reference

Journal of Inorganic Biochemistry

3 December 2017

published in

1 reference

3 December 2017

volume

95

1 reference

3 December 2017

issue

2-3

1 reference

3 December 2017

page(s)

165-170

1 reference

Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Development of matrix metalloproteinase inhibitors in cancer therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Crystal structures of recombinant 19-kDa human fibroblast collagenase complexed to itself

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Expression of matrix metalloproteinases and the metastasis-associated gene S100A4 in human neuroblastoma and primitive neuroectodermal tumor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Proteolysis in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Design and therapeutic application of matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Fragments of human fibroblast collagenase: interaction with metalloproteinase inhibitors and substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

A phase II trial of marimastat in advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

A pilot study of the safety and effects of the matrix metalloproteinase inhibitor marimastat in gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Metal ion-tetracycline interactions in biological fluids. Part 8. Potentiometric and spectroscopic studies on the formation of Ca(II) and Mg(II) complexes with 4-dedimethylamino-tetracycline and 6-desoxy-6-demethyl-tetracycline

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Pictet-Spengler condensation of the antiparkinsonian drug L-DOPA with D-glyceraldehyde. Opposite kinetic effects of Fe3+ and Cu2+ ions and possible implications for the origin of therapeutic side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Quantitative investigation of copper(II) and zinc(II) complexes with S-carboxymethyl-L-cysteine and computer-simulated appraisal of their potential significance in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Amplification of doxorubicin mutagenicity by cupric ion.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Proton NMR studies of Co(II) complexes of the peptide antibiotic bacitracin and analogues: insight into structure-activity relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Carbonic anhydrase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Aluminum chloride pretreatment of elastin inhibits elastolysis by matrix metalloproteinases and leads to inhibition of elastin-oriented calcification

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Inhibition of human gingival gelatinases (MMP-2 and MMP-9) by metal salts

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Activation of macrophage promatrix metalloproteinase-9 by lipopolysaccharide-associated proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Characteristics of a 95-kDa matrix metalloproteinase produced by mammary carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Cobalt as probe and label of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Protease inhibitors: synthesis of a series of bacterial collagenase inhibitors of the sulfonyl amino acyl hydroxamate type

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Preparation and reconstitution with divalent metal ions of class I and class II Clostridium histolyticum apocollagenases

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

Preparation by direct metal exchange and kinetic study of active site metal substituted class I and class II Clostridium histolyticum collagenases

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2803%2900100-4

7 January 2021

10.1016/S0162-0134(03)00100-4

Identifiers

DOI

1 reference

3 December 2017

1 reference